These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7260993)

  • 1. [Levamisole and its effect on the E-rosette restoration test in healthy subjects and in systemic lupus erythematosus (author's transl)].
    Rovenský J; Pekárek J; Holt PJ; Mistina T; Zitnan D
    Cas Lek Cesk; 1981 Jun; 120(25):761-3. PubMed ID: 7260993
    [No Abstract]   [Full Text] [Related]  

  • 2. Levamisole in systemic lupus erythematosus.
    Ogawa K; Sano T; Hisano G; Tsubura E
    Ann Allergy; 1979 Sep; 43(3):187-9. PubMed ID: 314248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vitro effect of levamisole on histamine inhibited E-rosette forming T-lymphocyte subpopulation in patients affected by disseminated erythematosus lupus.
    Pozsonyi T; Jakab L; Fehér J; Cseh K
    Allergol Immunopathol (Madr); 1982; 10(6):435-9. PubMed ID: 6220589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levamisole in the treatment of systemic lupus erythematosus--preliminary results.
    Feng PH; Oon CJ; Yo SL; Lau YK
    Singapore Med J; 1978 Sep; 19(3):120-4. PubMed ID: 751195
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of levamisole (Decaris) on various immunologic parameters in patients with systemic lupus erythematosus].
    Gandzha IM; Sakharchuk VM; Lysenko GI
    Ter Arkh; 1981; 53(7):121-4. PubMed ID: 6457406
    [No Abstract]   [Full Text] [Related]  

  • 6. The in vitro effect of thymic humoral factor and levamisole on peripheral blood lymphocytes in systemic lupus erythematosus patients.
    Michalevicz R; Many A; Ramot B; Trainin N
    Clin Exp Immunol; 1978 Jan; 31(1):111-5. PubMed ID: 639342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical experience with levamisole treatment of patients with systemic lupus erythematosus (author's transl)].
    Scherak O; Smolen J; Kolarz G; Kojer M; Menzel J
    Wien Klin Wochenschr; 1979 Nov; 91(22):758-62. PubMed ID: 160142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Our experiences with levamisole treatment in systemic lupus erythematosus (author's transl)].
    Rovenský J; Zitńan D; Cebecauer L; Lukác J
    Bratisl Lek Listy; 1981 May; 75(5):603-10. PubMed ID: 7016260
    [No Abstract]   [Full Text] [Related]  

  • 9. Study of lymphocyte subpopulations in patients with systemic lupus erythematosus. In vitro effect of levamisole on T-lymphocyte population.
    Pozsonyi T; Jakab L; Fehér J
    Allergol Immunopathol (Madr); 1980; 8(5):553-8. PubMed ID: 6970515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunotherapy of lupus erythematosus].
    Glavinskaia TA; Kurnikov GIu; Pavlova LT
    Vestn Dermatol Venerol; 1982 Jul; (7):4-8. PubMed ID: 7136252
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of systemic lupus erythematosus with the T-cell immunopotentiator levamisole: a follow-up report of 16 patients under treatment for a minimum period of four months.
    Gordon BL; Yanagihara R
    Ann Allergy; 1977 Oct; 39(4):227-36. PubMed ID: 71868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of levamisole in the adjuvant therapy of rheumatoid arthritis and systemic lupus erythematosus].
    Gandzha IM; Sakharchuk VM; Lysenko GI; Mironova KA; Galetskaia TM
    Vrach Delo; 1981 Feb; (2):16-8. PubMed ID: 7222600
    [No Abstract]   [Full Text] [Related]  

  • 13. [Increased immune reactivity in systemic lupus erythematosus. III. Different in vitro stimulation of lymphocytic populations by mitogenic serum factors (author's transl)].
    Günther W; Diezel W; Meffert H; Sönnichsen N
    Dermatol Monatsschr; 1978 Oct; 164(10):711-4. PubMed ID: 310779
    [No Abstract]   [Full Text] [Related]  

  • 14. [T-lymphocyte values in peripheral blood in systemic lupus erythematosus and similar nosological entities (progressive systemic sclerosis, rheumatoid arthritis, and mixed connective tissue disease) (author's transl)].
    Rovenský J; Jarosková L; Zitnan D; Pekábek J; Svejcar J
    Cas Lek Cesk; 1982 Mar; 121(12):370-4. PubMed ID: 6979391
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diagnosis of T-immunodeficiencies in lupus erythematosus and patient treatment with levamisole].
    Shaposhnikov OK; Gorbunov VF
    Vestn Dermatol Venerol; 1979 Mar; (3):3-6. PubMed ID: 311566
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter: Treatment of systemic lupus erythematosus with levamisole.
    Kassan SS
    Ann Allergy; 1976 Aug; 37(2):148-50. PubMed ID: 970682
    [No Abstract]   [Full Text] [Related]  

  • 17. The treatment of systemic lupus erythematosus (SLE) with the T-cell immunostimulant drug levamisole: A case report.
    Gordon BL; Keenan JP
    Ann Allergy; 1975 Dec; 35(6):343-55. PubMed ID: 1081857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Levamisole and heparin depot in the treatment of rapidly progressing glomerulonephritis in systemic lupus erythematosus].
    Klinger M; Klimkiewicz E
    Wiad Lek; 1978 Dec; 31(24):1743-6. PubMed ID: 735087
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative evaluation of the effect of carbidine and levamisole on the E-rosette-forming activity of the lymphocytes in alcoholic intoxication].
    Proskuriakova TV; Gurtovenko VM; Gorshkova EP
    Farmakol Toksikol; 1989; 52(1):94-8. PubMed ID: 2565251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interference of levamisole with inhibition of E-rosette formation by Hodgkin's disease and systemic lupus erythematosus cytotoxic sera.
    Del Giacco GS; Tognella S; Leone AL; Locci F; Cornaglia P; Sangiuolo A; Grifoni V
    Blood; 1979 May; 53(5):1002-6. PubMed ID: 435634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.